ChemoCentryx down 16% after Q2 revenue miss [Seeking Alpha]
ChemoCentryx, Inc. (CCXI)
Last chemocentryx, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.chemocentryx.com
Company Research
Source: Seeking Alpha
ChemoCentryx down 16% after Q2 revenue miss ChemoCentryx ( CCXI -16.3% Q2 results Revenue was down 45% to $7.2M due to a higher proportion of avacopan-related costs related to budgeted costs incurred last year under its commercialization agreements with Vifor Pharma. Net loss: ($15.2M); loss/share: ($0.26). Topline data from the Phase 3 ADVOCATE study of avacopan in ANCA-associated vasculitis should be available in Q4. Topline data from three other clinical trials, one for CCX140 (focal segmental glomerulosclerosis) and and two for avacopan (C3 glomerulopathy and hidradenitis suppurativa), should be available in 2020. Previously: ChemoCentryx, Inc. EPS misses by $0.04, misses on revenue
Show less
Read more
Impact Snapshot
Event Time:
CCXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CCXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CCXI alerts
High impacting ChemoCentryx, Inc. news events
Weekly update
A roundup of the hottest topics